ENT Devices Market - By Product (Diagnostic Ear, Nose, And Throat Devices, Surgical Ear, Nose, And Throat Devices, Hearing Aids, Hearing Implants, Voice Prosthesis Devices, Nasal Splints), End-use & Forecast, 2023-2032

ENT Devices Market - By Product (Diagnostic Ear, Nose, And Throat Devices, Surgical Ear, Nose, And Throat Devices, Hearing Aids, Hearing Implants, Voice Prosthesis Devices, Nasal Splints), End-use & Forecast, 2023-2032

ENT Devices Market Size

ENT Devices Market size was valued at over USD 19.5 billion in 2022. Driven by the surging geriatric population globally, the industry is anticipated to grow at over 6% CAGR from 2023 to 2032. 
 

The elderly population is highly susceptible to ear, neck, and throat disorders due to functional and anatomic changes to their bodies, which creates a strong need for hospital visits and effective diagnosis within this demographic. As per the American Academy of Audiology, 1 in every 3 people above 60 years and 1 in every 2 people above 85 years have hearing loss. Rising prevalence of these disorders has bolstered the need for ENT devices for the examination of ear, neck, and throat conditions.
 

Prohibitive costs of ENT examination and devices may constrain industry development

Despite a growing demand from the expanding geriatric population, steep costs associated with ENT devices and procedures are some of the major growth-hampering factors for the ENT devices market. The high prices make ENT devices an unaffordable luxury for many patients and small to medium-sized healthcare facilities. In fact, the average cost of hearing aids typically lies within the USD 1500 to USD 3500 range, holding back mass adoption of the product. This is more prominent in low and middle-income nations, where the high cost of advanced ENT devices and the dearth of skilled medical practitioners make ENT procedures and devices uncommon.
 

ENT Devices Market Analysis

Based on product, ENT devices market size from hearing aids segment recorded a valuation of over USD 7.3 billion in 2022. Growing occurrence of hearing disabilities has proliferated the demand for hearing aids globally. In fact, as per the WHO, an estimated 2.5 billion people across the globe are likely to suffer from some degree of hearing loss by 2050, with at least 700 million people needing hearing rehabilitation. Additionally, segment expansion can also be attributed to growing focus of industry players on R&D activities to bring forth innovations in hearing aids.
 

In terms of end-use, ENT devices market share from hospitals segment was valued at over USD 13.5 billion in 2022. Better availability of expert surgeons who can perform complex and even sensitive diagnostic procedures ensures higher patient footfall in hospitals. These facilities also have a wide range of cutting-edge ENT equipment that give medical practitioners a high level of precision during operation and diagnostic procedures, which further sways patient preference.
 

Growing efforts by world governments to strengthen their hospital infrastructure are further creating a notable impetus for segment expansion. Back in October 2022, the U.S. government announced an investment of over USD 110 million for supporting rural hospitals.
 

North America ENT devices market is expected to record a valuation of over USD 12.5 billion by 2032. Surging incidence of nasal, throat, and hearing disorders in the region has spurred the demand for ENT devices. As per the National Institute on Deafness and Other Communication Disorders, nearly two to three children out of 1,000 are born with detectable hearing loss in one or both ears in the U.S. alone.
 

Regional expansion can also be attributed to favorable government initiatives for hearing aids in the U.S. For instance, back in August 2022, the U.S. FDA rolled out a new regulatory framework to increase access to low-cost OTC hearing aids in the country.
 

ENT Devices Market Share

Some of the major ENT devices market players are

• William Demant Holding A/S
• Smith & Nephew
• Surgiform Innovative Surgical Products
• PENTAX Medical
• Stryker Corporation,
•  Medtronic

Back in June 2022, Demant, A/S, a Denmark-based hearing healthcare company, announced the acquisition of Sheng Wang, a hearing care retail chain based out of China.
 

This strategic move is expected to help the company increase its customer reach and broaden its product portfolio while maximizing its revenue.
 

The Ear-Nose-Throat devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments

By Product

• Diagnostic ENT Devices
  • Rigid Endoscopes
    • Rhinoscopes
    • Laryngoscopes
    • Otological Endoscopes
  • Flexible Endoscopes
  • Robot Assisted Endoscope
  • Hearing Screening Device
• Surgical ENT Devices
  • Radiofrequency Handpieces
  • Powered Surgical Instrument
  • Otological Drill Burrs
  • ENT Hand Instruments
  • Tympanostomy Tubes
  • Sinus Dilation Devices
  • Nasal Packing Devices
• Hearing Aids
  • Behind-the-ear (BTE)
  • Completely-in-the-canal/Invisible-in-canal (CIC/IIC)
  • In-the-canal (ITC)
  • In-the-ear (ITE)
  • Receiver in the ear/Receiver in Canal (RITE/RIC) 
• Hearing Implants
  • Auditory brainstem implants
  • Cochlear implants
  • Middle Ear implants
  • Bone anchored hearing system
• Voice Prosthesis Devices
• Nasal Splints
  • Internal nasal splints
  • External nasal splints

By End-use

• Hospitals
• Ambulatory Surgical Centers
• ENT Clinics
• Homecare

The above information is provided for the following  regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Egypt